Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.94 USD | -15.62% | -15.36% | +3.15% |
03:57pm | Needham Downgrades Collegium Pharmaceutical to Hold From Buy | MT |
01:26pm | Piper Downgrades Collegium Pharmaceutical to Neutral From Overweight, Price Target at $39 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.15% | 1.24B | |
+30.99% | 695B | |
+26.51% | 568B | |
-4.61% | 361B | |
+19.66% | 330B | |
+3.85% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+8.90% | 168B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Cantor Fitzgerald Upgrades Collegium Pharmaceutical to Overweight From Neutral; Price Target is $26